Well Woman

Latest News

RE104 aims to become the first psychedelic to treat postpartum depression
RE104 aims to become the first psychedelic to treat postpartum depression

October 16th 2024

Reunion Neuroscience is enrolling patients in its phase 2 RECONNECT trial to assess a single-dose synthetic psychedelic to treat the depressive symptoms of PPD.

Ensuring successful treatment of anemia in pregnancy | Image Credit: © RFBSIP - © RFBSIP - stock.adobe.com.
Ensuring successful treatment of anemia in pregnancy

October 14th 2024

High infective endocarditis rates found among women who inject drugs | Image Credit: © Syda Productions - © Syda Productions - stock.adobe.com.
High infective endocarditis rates found among women who inject drugs

October 7th 2024

Family history criteria used to predict breast cancer genetic risk variants | Image Credit: © okrasiuk - © okrasiuk - stock.adobe.com.
Family history criteria used to predict breast cancer genetic risk variants

September 26th 2024

Breast arterial calcifications linked to cardiovascular disease risk | Image Credit: © BillionPhotos.com - © BillionPhotos.com - stock.adobe.com.
Breast arterial calcifications linked to cardiovascular disease risk

September 12th 2024

Video Interviews
Podcasts

More News

© 2024 MJH Life Sciences

All rights reserved.